Qube Research & Technologies LTD Seres Therapeutics, Inc. Transaction History

Qube Research & Technologies LTD

  • $62.3 Billion
  • Q2 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024
BUY
$0.93 - $2.15 $441,855 - $1.02 Million
475,113 Added 287.0%
640,655 $896,000
Q3 2023

Nov 13, 2023
BUY
$2.33 - $5.07 $385,712 - $839,297
165,542 New
165,542 $393,000
Q2 2022

Aug 15, 2022
BUY
$2.7 - $7.62 $47,733 - $134,713
17,679 Added 119.54%
32,468 $111,000
Q1 2022

May 09, 2022
SELL
$6.3 - $8.84 $818,546 - $1.15 Million
-129,928 Reduced 89.78%
14,789 $105,000
Q4 2021

Feb 01, 2022
BUY
$6.02 - $11.43 $871,196 - $1.65 Million
144,717 New
144,717 $1.21 Million

Others Institutions Holding MCRB

# of Institutions
96
Shares Held
46.3M
Call Options Held
119K
Put Options Held
466K
View Full List

About Seres Therapeutics, Inc.

MCRB Quotes by TradingView
  • Ticker MCRB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 124,072,000
  • Market Cap $114M
  • Description
  • Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...
More about MCRB
Track This Portfolio

Track Qube Research & Technologies LTD Portfolio

Follow Qube Research & Technologies LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email